Skip to main content
SpringerLink
Log in

Aktuelle Datenlage

Mikronährstoffe beim Prostatakarzinom

  • Uroonkologie
  • Fortbildung
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Wien TN et al. Cancer risk with folic acid supplements: A systematic review and meta-analysis. BMJ Open. 2012;2: e000653.

  2. Nordström T et al. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016;76:339-48

  3. Margalit DN et al. Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians' Health Study. J Radiat Oncol Biol Phys. 2012;83:28-32

  4. Ehrenpreis ED et al. A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy. Dis Colon Rectum. 2005;48:1-8

  5. Bai XY et al. Association between Dietary Vitamin C Intake and Risk of Prostate Cancer: A Meta-analysis Involving 103,658 Subjects. J Cancer. 2015;6:913-21

  6. Campbell GD Jr et al. Letter: Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med. 1975;82:810

  7. Rees DC et al. Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency. BMJ. 1993;306:841-2

  8. McCullough ML et al. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr. 2009;29:111-32

  9. Stanaland M et al. Study of the Association Between Serum Vitamin D Levels and Prostate Cancer. Military medicine 2017;182:e1769-74

  10. Albanes D et al. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev. 2011;20:1850-60

  11. Meyer HE et al. Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies. Am J Clin Nutr. 2013;97:147-54

  12. Gilbert R et al. Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment study. Cancer Causes Control. 2012;23:575-88

  13. Wagner D et al. Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients. J Clin Endocrinol Metab. 2013;98:1498-507

  14. Nyame YA et al. Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy. J Clin Oncol. 2016;34:1345-9

  15. Mondul AM et al. Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival. Cancer epidemiology, biomarkers & prevention. Cancer Epidemiol Biomarkers Prev. 2016;25:665-9

  16. Mücke R et al. Komplementärer Seleneinsatz in der Onkologie. Der Onkologe. 2010;16:181-6

  17. Bleys J et al. Serum selenium levels and all cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008;168:404-10

  18. Lippman SM et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009;301:39-51

  19. Mücke R et al. German Working Group Trace Elements and Electrolytes in Oncology. Selenium or no selenium-that is the question in tumor patients: a new controversy. Integr Cancer Ther. 2010;9:136-41

  20. Geybels MS et al. Advanced prostate cancer risk in relation to toenail selenium Levels. J Natl Cancer Inst. 2013;105:1394-401

  21. Kristal AR et al. Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer Risk. J Natl Cancer Inst. 2014;106:djt456

  22. Kim Y et al. Relation of Vitamin E and Selenium Exposure to Prostate Cancer Risk by Smoking Status: A Review and Meta-Analysis. Anticancer Res. 2015;35:4983-96

  23. Chan JM et al. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT. Cancer Epidemiol Biomarkers Prev. 2016;25:1050-8

  24. Xie W et al. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis. The Prostate. 2016;76:691-9

  25. Allen NE et al. Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies. J Natl Cancer Inst. 2016;https://doi.org/10.1093/jnci/djw153

  26. Cai X et al. Selenium Exposure and Cancer Risk: an Updated Meta-analysis and Meta-regression. Sci Rep. 2016;6: 19213

  27. Outzen M et al. Selenium status and risk of prostate cancer in a Danish population. Br J Nutr. 2016;115: 1669-77

  28. Cui Z et al. Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis. Medicine. Feb 2017;96: e5944.

  29. Sayehmiri K et al. The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2018;19: 1431-7

  30. Kranse R et al. Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study. Int J Cancer. 2005;113: 835-40

  31. Stratton MS et al. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer. Cancer Prev Res (Phila). 2010;3:1035-43

  32. Kenfield SA et al. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2014;107: 360

  33. Ansong E et al. Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer. PloS one. 2015;10: e0127295

  34. Meyer F et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer. 2005;116: 182-6

  35. Leitzmann MF et al. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003;95: 1004-7

  36. Zhang Y et al. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control. 2009;20: 691-8

Download references

Author information

Authors and Affiliations

  1. Abtlg. f. Strahlentherapie, Klinikum Weiden, Söllner Str. 16, 92637, Weiden, Germany

    Ralph Mücke

Authors
  1. Ralph Mücke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oliver Micke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jens Büntzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Irenäus Adamietz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Khashayar Fakhrian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mücke, R., Micke, O., Büntzel, J. et al. Mikronährstoffe beim Prostatakarzinom. Im Fokus Onkologie 23, 30–33 (2020). https://doi.org/10.1007/s15015-020-2435-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-020-2435-x

Search

Navigation